During the year ended 30th September 2025, the Company became the parent undertaking of Facial Aesthetic & Cosmetic Enhancement Clinic Limited by way of a share-for-share exchange. The shareholders of the subsidiary exchanged their shares for shares in the Company, resulting in the Company acquiring 100% of the issued share capital of Facial Aesthetic & Cosmetic Enhancement Clinic Limited.
The transaction represents a group reconstruction under common control. Accordingly, the investment in the subsidiary has been accounted for using merger accounting principles in accordance with FRS 102.
The investment has been recorded at the nominal value of the shares issued in exchange for the shares acquired. No fair value adjustments have been made to the underlying assets and liabilities of the subsidiary.
Any difference arising between the nominal value of the shares issued and the nominal value of the shares acquired has been recognised in equity within other reserves.